Skip to main content

Table 4 PRISMA checklist

From: Effectiveness of mesenchymal stem cell-conditioned medium in bone regeneration in animal and human models: a systematic review and meta-analysis

Section/topic#Checklist itemReported on page # 
TITLE 
Title1Identify the report as a systematic review, meta-analysis, or both.Yes 
ABSTRACT 
Structured summary2Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and implications of key findings; systematic review registration number.Yes 
INTRODUCTION 
Rationale3Describe the rationale for the review in the context of what is already known.Yes 
Objectives4Provide an explicit statement of questions being addressed with reference to participants, interventions, comparisons, outcomes, and study design (PICOS).Yes 
METHODS 
Protocol and registration5Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide registration information including registration number.No 
Eligibility criteria6Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, language, publication status) used as criteria for eligibility, giving rationale.Yes 
Information sources7Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify additional studies) in the search and date last searched.Yes 
Search8Present full electronic search strategy for at least one database, including any limits used, such that it could be repeated.Yes 
Study selection9State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, included in the meta-analysis).Yes 
Data collection process10Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes for obtaining and confirming data from investigators.Yes 
Data items11List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and simplifications made.Yes 
Risk of bias in individual studies12Describe methods used for assessing risk of bias of individual studies (including specification of whether this was done at the study or outcome level), and how this information is to be used in any data synthesis.Yes 
Summary measures13State the principal summary measures (e.g., risk ratio, difference in means).Yes 
Synthesis of results14Describe the methods of handling data and combining results of studies, if done, including measures of consistency (e.g., I2) for each meta-analysis.Yes 
Section/topic#Checklist itemReported on page #
Risk of bias across studies15Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective reporting within studies).yes
Additional analyses16Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, indicating which were pre-specified.No
 RESULTS
Study selection17Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions at each stage, ideally with a flow diagram.Yes
Study characteristics18For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) and provide the citations.Yes
Risk of bias within studies19Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).Yes
Results of individual studies20For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.Yes
Synthesis of results21Present results of each meta-analysis done, including confidence intervals and measures of consistency.Yes
Risk of bias across studies22Present results of any assessment of risk of bias across studies (see Item 15).Yes
Additional analysis23Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).No
 DISCUSSION
Summary of evidence24Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers).Yes
Limitations25Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).Yes
Conclusions26Provide a general interpretation of the results in the context of other evidence, and implications for future research.Yes
 FUNDING
Funding27Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for the systematic review.Yes